145 related articles for article (PubMed ID: 31226385)
1. An herbal-compound-based combination therapy that relieves cirrhotic ascites by affecting the L-arginine/nitric oxide pathway: A metabolomics-based systematic study.
Zhang K; Zhang Y; Li N; Xing F; Zhao J; Yang T; Liu C; Feng N
J Ethnopharmacol; 2019 Sep; 241():112034. PubMed ID: 31226385
[TBL] [Abstract][Full Text] [Related]
2. Effect of L-NAME on nitric oxide and gastrointestinal motility alterations in cirrhotic rats.
Wang X; Zhong YX; Zhang ZY; Lu J; Lan M; Miao JY; Guo XG; Shi YQ; Zhao YQ; Ding J; Wu KC; Pan BR; Fan DM
World J Gastroenterol; 2002 Apr; 8(2):328-32. PubMed ID: 11925618
[TBL] [Abstract][Full Text] [Related]
3. Effects of Chinese herbal cataplasm Xiaozhang Tie on cirrhotic ascites.
Xing F; Tan Y; Yan GJ; Zhang JJ; Shi ZH; Tan SZ; Feng NP; Liu CH
J Ethnopharmacol; 2012 Jan; 139(2):343-9. PubMed ID: 22107835
[TBL] [Abstract][Full Text] [Related]
4. Multicomponent, multitarget integrated adjustment - Metabolomics study of Qizhiweitong particles curing gastrointestinal motility disorders in mice induced by atropine.
Chang X; Wang S; Bao YR; Li TJ; Yu XM; Meng XS
J Ethnopharmacol; 2016 Aug; 189():14-21. PubMed ID: 27180317
[TBL] [Abstract][Full Text] [Related]
5. [Study of Chinese herbal medicine in treating ascites and their mechanism in regulating lymphatic stomata].
Wu Y; Li JC; Mao LG
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Sep; 21(9):677-9. PubMed ID: 12575556
[TBL] [Abstract][Full Text] [Related]
6. Regulating effect of Chinese herbal medicine on the peritoneal lymphatic stomata in enhancing ascites absorption of experimental hepatofibrotic mice.
Li JC; Ding SP; Xu J
World J Gastroenterol; 2002 Apr; 8(2):333-7. PubMed ID: 11925619
[TBL] [Abstract][Full Text] [Related]
7. Interpretation of Euphorbia Kansui Stir-Fried with Vinegar Treating Malignant Ascites by a UPLC-Q-TOF/MS Based Rat Serum and Urine Metabolomics Strategy Coupled with Network Pharmacology.
Zhang Y; Gao J; Zhang Q; Wang K; Yao W; Bao B; Zhang L; Tang Y
Molecules; 2018 Dec; 23(12):. PubMed ID: 30544627
[No Abstract] [Full Text] [Related]
8. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites.
Martin PY; Ohara M; Gines P; Xu DL; St John J; Niederberger M; Schrier RW
J Clin Invest; 1998 Jan; 101(1):235-42. PubMed ID: 9421486
[TBL] [Abstract][Full Text] [Related]
9. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
10. [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].
Ortiz MC; Fortepiani LA; Martínez-Salgado C; Eleno N; Atucha NM; López-Novoa JM; García-Estañ J
Nefrologia; 2001; 21(6):556-64. PubMed ID: 11881425
[TBL] [Abstract][Full Text] [Related]
11. Clinical research on navel application of Shehuang Paste combined with Chinese herbal colon dialysis in treatment of refractory cirrhotic ascites complicated with azotemia.
Tong GD; Zhou DQ; He JS; Zhang L; Chen ZF; Xiao CL; Peng LS
World J Gastroenterol; 2006 Dec; 12(48):7798-804. PubMed ID: 17203523
[TBL] [Abstract][Full Text] [Related]
12. Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites.
Clària J; Jiménez W; Ros J; Rigol M; Angeli P; Arroyo V; Rivera F; Rodés J
Hepatology; 1994 Dec; 20(6):1615-21. PubMed ID: 7527007
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.
López-Talavera JC; Levitzki A; Martínez M; Gazit A; Esteban R; Guardia J
J Clin Invest; 1997 Aug; 100(3):664-70. PubMed ID: 9239414
[TBL] [Abstract][Full Text] [Related]
14. Increased renal expression of nitric oxide synthase type III in cirrhotic rats with ascites.
Bosch-Marcé M; Morales-Ruiz M; Jiménez W; Bordas N; Solé M; Ros J; Deulofeu R; Arroyo V; Rivera F; Rodés J
Hepatology; 1998 May; 27(5):1191-9. PubMed ID: 9581670
[TBL] [Abstract][Full Text] [Related]
15. Targeted arginine metabolomics combined with metagenomics revealed the potential mechanism of Pueraria lobata extract in treating myocardial infarction.
Yi B; Zhao Y; Yan H; Li Z; Zhang P; Fang Z; Zhao Y; Yang H; Guo N
J Chromatogr A; 2024 Mar; 1719():464732. PubMed ID: 38387153
[TBL] [Abstract][Full Text] [Related]
16. [Study on intervention effect of Danggui Shaoyao San on rats with cirrhotic ascites].
Wang CY; Xu F; Wang MY; Xuan ZH; Hu SY; Zhou Y; Lu J
Zhongguo Zhong Yao Za Zhi; 2013 Mar; 38(6):871-4. PubMed ID: 23717970
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide.
Clària J; Jiménez W; Ros J; Asbert M; Castro A; Arroyo V; Rivera F; Rodés J
Hepatology; 1992 Feb; 15(2):343-9. PubMed ID: 1735539
[TBL] [Abstract][Full Text] [Related]
18. Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis.
Xu L; Carter EP; Ohara M; Martin PY; Rogachev B; Morris K; Cadnapaphornchai M; Knotek M; Schrier RW
Am J Physiol Renal Physiol; 2000 Dec; 279(6):F1110-5. PubMed ID: 11097630
[TBL] [Abstract][Full Text] [Related]
19. Broad range metabolomics coupled with network analysis for explaining possible mechanisms of Er-Zhi-Wan in treating liver-kidney Yin deficiency syndrome of Traditional Chinese medicine.
Zhai Y; Xu J; Feng L; Liu Q; Yao W; Li H; Cao Y; Cheng F; Bao B; Zhang L
J Ethnopharmacol; 2019 Apr; 234():57-66. PubMed ID: 30690072
[TBL] [Abstract][Full Text] [Related]
20. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide.
Castro A; Jiménez W; Clària J; Ros J; Martínez JM; Bosch M; Arroyo V; Piulats J; Rivera F; Rodés J
Hepatology; 1993 Aug; 18(2):367-72. PubMed ID: 8340065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]